NEWS
A bio company owning antibody fragment-based technology and development innovative biologics
TABLE
No Title Written by Written date Hits
1 AprilBio, 'SAFA Platform' Bind to Albumin.."Entering Clinical Trials This Year" Admin 21.05.06 1